Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Bank of America
BAC
|
+$1.46B |
| 2 |
JPMorgan Chase
JPM
|
+$1.36B |
| 3 |
Wells Fargo
WFC
|
+$1.15B |
| 4 |
Microsoft
MSFT
|
+$1.09B |
| 5 |
Goldman Sachs
GS
|
+$891M |
Top Sells
| 1 |
Medtronic
MDT
|
+$1.18B |
| 2 |
Roper Technologies
ROP
|
+$1.12B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.07B |
| 4 |
NVIDIA
NVDA
|
+$1.07B |
| 5 |
Visa
V
|
+$1.01B |
Sector Composition
| 1 | Financials | 16.49% |
| 2 | Technology | 14.94% |
| 3 | Healthcare | 13.4% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEB.PRC
2026
DELISTED
Pebblebrook Hotel Trust 6.50% Series C
PEB.PRC
| $6.87M | ﹤0.01% |
+282,509
| New | +$6.87M |
|
2027
Realty Income
O
$54.2B
| $6.86M | ﹤0.01% |
123,151
-4,427
| -3% | -$247K |
|
2028
El Pollo Loco
LOCO
$306M
| $6.85M | ﹤0.01% |
557,000
-493,800
| -47% | -$6.07M |
|
2029
NETSCOUT
NTCT
$1.8B
| $6.85M | ﹤0.01% |
217,417
-53,200
| -20% | -$1.68M |
|
2030
Vanguard Materials ETF
VAW
$2.86B
| $6.81M | ﹤0.01% |
60,531
-37,093
| -38% | -$4.17M |
|
2031
SPDR S&P Biotech ETF
XBI
$5.41B
| $6.75M | ﹤0.01% |
+113,998
| New | +$6.75M |
|
2032
Vanguard FTSE Emerging Markets ETF
VWO
$99.2B
| $6.73M | ﹤0.01% |
188,086
+79,929
| +74% | +$2.86M |
|
2033
Lesaka Technologies
LSAK
$376M
| $6.69M | ﹤0.01% |
583,000
-10,000
| -2% | -$115K |
|
|
AGEN
2034
Agenus
AGEN
$154M
| $6.68M | ﹤0.01% |
82,579
-27,148
| -25% | -$2.2M |
|
|
DS
2035
DELISTED
Drive Shack Inc.
DS
| $6.68M | ﹤0.01% |
1,775,361
-274,000
| -13% | -$1.03M |
|
2036
Myriad Genetics
MYGN
$629M
| $6.63M | ﹤0.01% |
398,000
+315,882
| +385% | +$5.27M |
|
2037
Navient
NAVI
$1.31B
| $6.63M | ﹤0.01% |
403,719
-451,782
| -53% | -$7.42M |
|
2038
Bar Harbor Bankshares
BHB
$532M
| $6.63M | ﹤0.01% |
210,056
| – | – |
|
|
QTNA
2039
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $6.59M | ﹤0.01% |
+363,600
| New | +$6.59M |
|
2040
uniQure
QURE
$951M
| $6.58M | ﹤0.01% |
1,175,118
+46,200
| +4% | +$259K |
|
|
GSV
2041
DELISTED
Gold Standard Ventures Corp.
GSV
| $6.55M | ﹤0.01% |
3,062,200
+56,500
| +2% | +$121K |
|
2042
Crown Holdings
CCK
$10.9B
| $6.48M | ﹤0.01% |
123,291
+26,851
| +28% | +$1.41M |
|
2043
Forrester Research
FORR
$188M
| $6.46M | ﹤0.01% |
150,300
+22,845
| +18% | +$981K |
|
|
SPAN
2044
DELISTED
Span-America Medical Systems I
SPAN
| $6.45M | ﹤0.01% |
353,603
+11,552
| +3% | +$211K |
|
2045
Vanguard S&P 500 ETF
VOO
$735B
| $6.43M | ﹤0.01% |
31,218
+2,761
| +10% | +$569K |
|
2046
Diageo
DEO
$58B
| $6.43M | ﹤0.01% |
61,816
-10,432
| -14% | -$1.08M |
|
|
BOLD
2047
DELISTED
Audentes Therapeutics, Inc
BOLD
| $6.4M | ﹤0.01% |
350,000
| – | – |
|
2048
Immunic
IMUX
$86.9M
| $6.34M | ﹤0.01% |
36,447
| – | – |
|
2049
Moelis & Co
MC
$5.37B
| $6.3M | ﹤0.01% |
185,900
+91,800
| +98% | +$3.11M |
|
2050
MillerKnoll
MLKN
$1.38B
| $6.3M | ﹤0.01% |
184,250
-199,050
| -52% | -$6.81M |
|